NIH-funded research Career grant

Evaluating cervical cancer screening methods for women with HIV in Botswana

Official title: Evaluation of triage strategies and screening intervals in a human papillomavirus based cervical cancer screening program in women living with human immunodeficiency virus in Botswana

Funded at Beth Israel Deaconess Medical Center · NIH-11093576 · Data updated 2026-11-12

This study is looking at the best ways to screen for cervical cancer in women living with HIV in Botswana, and it invites 3,000 women to help find out which testing methods work best for keeping them healthy.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$255,961
NIH project number5K08CA271949-04
Project IDNIH-11093576 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women living with HIV in Botswana, particularly those aged 30 and older who are at risk for cervical cancer.

Less likely to help

Patients who are not living with HIV or those who do not reside in Botswana may not benefit from this research.

What this research studies

This research investigates the effectiveness of different cervical cancer screening methods using high-risk HPV testing specifically for women living with HIV in Botswana. It aims to establish a longitudinal cohort of 3,000 women, half of whom are HIV-positive, to assess the performance of various screening algorithms. Participants will undergo initial HPV testing followed by visual evaluations and biopsies to determine the best screening approach. The study seeks to provide evidence-based strategies for cervical cancer screening in high HIV prevalence settings.

Why it matters

Potential benefit: If successful, this research could lead to improved cervical cancer screening protocols for women living with HIV, potentially reducing cancer incidence and mortality in this vulnerable population.

How similar studies have gone: Previous research has shown that HPV-based screening can be effective in high-income countries, but this approach is being tested for the first time in a high HIV prevalence setting like Botswana.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Luckett, Rebecca — Beth Israel Deaconess Medical Center
  • Study coordinator: Luckett, Rebecca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.